Chemo Side Effects More Prevalent in Women Than Men

Your gender may influence how you experience chemotherapy side effects, as a new study has found that women are more likely to have them.

Researchers analyzed data from trials involving 1,654 patients that received different combinations of chemotherapy for esophageal and stomach cancer. For common chemo side effects like nausea, vomiting and diarrhea, women experienced significantly higher rates of those effects. For example, 89% of women experienced nausea and vomiting compared to 78% of men. And 81% of women saw hair loss compared to 74% of men.

Women were also more likely to suffer serious adverse events as a result of treatment that often led to hospitalization. Chemotherapy was found to have similar efficacy in both sexes in terms of survival, though men tended to experience a greater reduction in tumor size.

The researchers noted that the findings indicate that chemotherapy doses may need to be adjusted for women.

The results were presented at the recent European Society for Medical Oncology Congress and have yet to be published in a peer-reviewed medical journal.


Did you find this article helpful?


Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

More Drugs Linked to Heart Failure

More Drugs Linked to Heart Failure

Pulmonary arterial hypertension is a disease of the lungs that can cause heart failure and death, and it’s being linked to an increasing number of common and oft-prescribed drugs. The journal Prescrire, reports that, as of 2020, amphetamines, immunosuppressants, certain cancer medications, and a handful of other select medications have been…

Significant Side Effects Seen in Early Trial of COVID-19 Vaccine

Significant Side Effects Seen in Early Trial of COVID-19 Vaccine

There’s a COVID-19 vaccine on the way — or so the Wednesday headlines, which heralded positive results from Pfizer and BioNTech’s early-stage trial of a vaccine for COVID-19, would lead you to believe. A closer look at the data, and the adverse effects, however, reveals that it’s probably too early…

  • Advertisement